Ablative therapies for liver metastases of digestive endocrine tumours.
about
Intra-arterial hepatic chemoembolization in liver metastases from neuroendocrine tumors: a phase II study.Liver metastases of neuroendocrine tumours; early reduction of tumour load to improve life expectancyRecent trends in the treatment of well-differentiated endocrine carcinoma of the small bowel.ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors.Multimodal management of neuroendocrine liver metastases.Chemotherapy for gastro-enteropancreatic endocrine tumours.Hepatic neuroendocrine metastases: chemo- or bland embolization?Surgical treatment of advanced-stage carcinoid tumors: lessons learned.The role of cytoreductive hepatic surgery as an adjunct to the management of metastatic neuroendocrine carcinomas.Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumoursAggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated?The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant.Evolving treatment strategies for management of carcinoid tumors.Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Incidence, Risk Factors and Prognosis.Hepatic artery embolization in advanced neuroendocrine tumors: Efficacy and long-term outcomes.An overview of the surgical management of hepatic neuroendocrine metastases.Is there still a role for the hepatic locoregional treatment of metastatic neuroendocrine tumors in the era of systemic targeted therapies?Poorly differentiated small cell neuroendocrine carcinoma localized in three different endocrine glands: response to chemotherapy and octreotide LAR.
P2860
Q30835097-923B3483-2D95-4A3B-9945-72613322C5E6Q33247993-001041E8-E994-4C12-9924-1BC571694543Q33782024-92806CE9-CD4C-4E6B-B856-A9BFBB44A7F0Q34248487-8A54FFCF-0DD6-47CD-B91C-E99DA662A438Q34498450-6841F038-FFFE-4333-B7D7-5411994A0738Q34528199-3CAAF5B1-9D75-4426-8836-9C78E3E89854Q35915027-4DAC3243-12DE-4B1D-875C-BC4F406B4678Q35930191-349C2FFA-B804-4D53-93F1-DEA67A728BA1Q36136538-11B1A663-0BDD-4A49-ADAF-79A79038DCF3Q36409960-C15780F3-3E80-4CB8-9D3F-4DA189E1DD97Q36610557-80F40FEB-9A53-472C-9A6D-603B31F06CD4Q37277977-A9E593EA-87B8-4836-BECF-D25219D0124BQ37869391-9F2DDEBB-CCC7-4263-9D47-3E9FF5139FC7Q38124702-282F8F1D-FAED-4936-AA13-39402394B005Q38958621-CBD77022-7F01-4858-8E66-F8E529C59918Q41053501-360D9237-D067-4F92-8089-DD8000F6988DQ42032092-3E5149FE-027C-4827-B63D-2B8DAAA658F7Q42359114-A4F7C5C6-30DC-40CB-AFF5-3BC48517484BQ46556343-03B64544-E239-4FC9-88F3-740A25EE8B37
P2860
Ablative therapies for liver metastases of digestive endocrine tumours.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Ablative therapies for liver metastases of digestive endocrine tumours.
@ast
Ablative therapies for liver metastases of digestive endocrine tumours.
@en
type
label
Ablative therapies for liver metastases of digestive endocrine tumours.
@ast
Ablative therapies for liver metastases of digestive endocrine tumours.
@en
prefLabel
Ablative therapies for liver metastases of digestive endocrine tumours.
@ast
Ablative therapies for liver metastases of digestive endocrine tumours.
@en
P2093
P356
P1476
Ablative therapies for liver metastases of digestive endocrine tumours.
@en
P2093
P304
P356
10.1677/ERC.0.0100463
P577
2003-12-01T00:00:00Z